ThemeREX IPharm Deserialization Flaw Exposes Sites to Object Injection
A critical vulnerability in ThemeREX IPharm versions up to 1.2.4 allows untrusted data deserialization, posing a severe risk to WordPress installations.

Key points
- CVE-2026-93936 is rated Critical with a CVSS score of 9.8.
- The flaw affects ThemeREX IPharm versions from release through 1.2.4.
- The vulnerability involves CWE-502, the deserialization of untrusted data.
Organisations relying on the ThemeREX IPharm plugin for e-commerce must address a severe security gap identified in the National Vulnerability Database. The issue, tracked as CVE-2026-93936, carries a maximum CVSS score of 9.8, indicating a critical risk level for affected systems. This rating underscores the potential for significant compromise if the vulnerability is exploited by threat actors targeting WordPress environments.
What is the technical nature of this vulnerability?
The core issue lies in how the IPharm plugin processes incoming data, specifically allowing for the deserialization of untrusted data. According to the National Vulnerability Database, this weakness is classified under CWE-502. Deserialization vulnerabilities occur when an application automatically converts serialised data objects back into their original state without adequately validating the data's integrity or origin. This process can be manipulated to inject malicious objects.
In this specific instance, the flaw enables Object Injection. Attackers can craft malicious data streams that, when processed by the plugin, instantiate objects with arbitrary properties or methods. This mechanism bypasses standard input validation checks, allowing the attacker to control the state of the application. The National Vulnerability Database explicitly describes this as allowing Object Injection, which is a direct consequence of the untrusted data handling.
Which versions and components are affected?
The vulnerability impacts the ThemeREX Group IPharm plugin, a component often used for pharmaceutical-related e-commerce functionalities on WordPress sites. The National Vulnerability Database states that the issue affects IPharm versions starting from the earliest available release, designated as n/a, through version 1.2.4. Any installation running a version within this range is considered affected and potentially vulnerable to exploitation.
Users must verify their current plugin version to determine exposure. The range "from n/a through 1.2.4" implies that no version prior to the next release after 1.2.4 is considered safe by default. There is no mention of a patched version in the source material, meaning all versions up to 1.2.4 remain at risk. Organisations should audit their plugin repositories to identify any installations that fall within this specific version window.
How does this impact organisational security?
A CVSS score of 9.8 indicates that the vulnerability is exploitable over a network and requires no user interaction for successful exploitation in many scenarios. The critical rating suggests that an attacker could potentially achieve remote code execution or significant system compromise. For CISOs and IT managers, this represents a high-priority incident that requires immediate attention to prevent unauthorised access to sensitive customer data or backend systems.
The lack of authentication requirements for exploitation, typical of such high-severity deserialization flaws, means that automated scanners or targeted attacks could leverage this weakness quickly. The impact on organisations is direct: compromised integrity and confidentiality of the web application. Without mitigation, the affected plugin acts as an open door for malicious actors to inject and execute arbitrary code within the application context.
What is the current status of remediation?
The National Vulnerability Database record for CVE-2026-93936 does not confirm the existence of a patch or updated version that resolves the issue. Consequently, no fix has been confirmed yet by the vendor. Organisations should monitor official channels from ThemeREX Group for any announcements regarding a security update. In the interim, reducing the attack surface is the only viable defensive strategy.
IT teams should consider disabling the plugin if it is not actively required for business operations. If the plugin is essential, compensating controls such as web application firewalls may provide temporary protection. However, these measures are not substitutes for a proper vendor patch. Users must remain vigilant and check for updates regularly, as the situation remains unresolved according to the current source material.
Background: Web application firewalls
Web application firewalls do not replace secure coding. They block known attack patterns using signature matching but cannot understand business logic. Relying on them alone leaves your application vulnerable to business logic flaws, authenticated attacks, and complex payloads that bypass standard rules.
Read the full guide: Web Application Firewalls: 6 Common Misunderstandings to Avoid
What to do and how to stay safe: ThemeREX
- Audit all WordPress installations to identify and list versions of the ThemeREX IPharm plugin.
- Disable the plugin if it is not critical to immediate business operations to reduce exposure.
- Monitor vendor communications for an official security update or patch release.
- Implement strict input validation and web application firewall rules to filter suspicious data.
General security guidance from the Phish Herald newsroom. It is not confirmed advice from the organisations named in this story.
Frequently asked questions
What is the CVSS score for CVE-2026-93936?
The CVSS score is 9.8, which is rated as Critical.
Which versions of ThemeREX IPharm are vulnerable?
Versions from n/a through 1.2.4 are affected by this vulnerability.
Is there a patch available for this flaw?
No fix has been confirmed yet according to the source material.



